Derbyshire pharma firm launches £1m share offer
Derbyshire-based N4 Pharma has launched a drive to raise up to £1m through a broker offer.
N4 Pharma says it expects to bag around £250,000 through the offer, but that it may be extended to reach seven figures if over-subscribed.
The offer is being run through Turner Pope Investments (TPI). It opened at 7am this morning and will close at 4.30pm on Monday 21 November.
The issue price of the broker offer is 2 pence per new ordinary share.
Chellaston-based N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec®.
